Image

Essilor® Stellest® Lenses Multicentre European Study (SLOMES)

Recruiting
6 - 16 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this post-market clinical follow up Study is to demonstrate the efficacy, safety, acceptability, and quality of life implications of Essilor® Stellest® spectacle lenses in slowing myopia progression in European children and adolescents. Participants will receive Essilor® Stellest® at inclusion visit and will be asked for a full time wear (>12 hours daily) for 24 months. The primary endpoints are the change in axial length and cycloplegic autorefraction from baseline to 24 months compared to expected change based on axial length and refraction centile positions at baseline.

Description

The trial design is a multicentre, European, prospective, interventional study with single group assignment. The investigational medical device Essilor® Stellest® is a CE marked, myopia control spectacle lens. The trial period for all participants is 24 months. The recruiting period is 6 to 9 months depending on countries / sites for a total of 150 participants (50 in Ireland, 75 in France and 25 in The Netherlands).

The secondary objectives are:

  • To evaluate the acceptability of Essilor® Stellest® spectacle lenses in slowing myopia progression.
  • To evaluate the quality-of-life implications for children and adolescents.
  • To evaluate the safety of Essilor® Stellest® spectacle lenses in slowing myopia progression.
  • To evaluate the effect of Essilor® Stellest® spectacle lenses on choroidal thickness.

Eligibility

Inclusion Criteria:

  1. - Myopia as determined by cycloplegic autorefraction as follows:
    • Each meridian SER of plano to - 8;00 D in each eye
    • Astigmatism < 2.50 D
    • Anisometropia ≤ 1.50 D
  2. - Monocular corrected VA of at least 0.2 LogMAR in both eyes
  3. - Age: 6 - 16 years old, inclusive at the time of inclusion
  4. - Ability to understand treatment and give valid assent
  5. - Ability to comply with the protocol to get reliable study measurements

Exclusion Criteria:

  1. - Concomitant or previous therapies for myopia
  2. - Eye diseases/conditions:
    • Strabismus by cover test at near or distance
    • Any ocular disease that would influence refractive development e.g. retinal disease, cataract, ptosis
    • Any systemic or neurodevelopmental conditions that may influence refractive development
  3. - Use of ocular or systemic medication which may affect myopia progression or visual

    acuity through known effects on retina, accommodation, or significant elevation of intraocular pressure

  4. - Participation in another study which may influence vision or interfere with study assessments
  5. - Myopia onset before 5 years of age
  6. - Contact lens wearers

Study details

Myopia

NCT06263946

Essilor International

29 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.